# ulcerative colitis (UC) - glm-5.2

- Benchmark system: E2seq + Agent RAG
- Repeat: 2
- Task type: DISEASE-STATE
- Tissue / sample source: colonic mucosal tissue
- Comparison or endpoint: ulcerative colitis versus healthy control
- Answer input cohort: Discovery/Core only
- Selected items: 100
- Input fields: gene name, effect size (log2FC/HR), P value, FDR
- E2seq Agent RAG: enabled
- Conversation memory: disabled
- Thinking mode: disabled
- Held-out validation data in prompt/RAG: no
- Model API: Zhipu AI / glm-5.2
- Message SHA-256: 478acec7ab00f0e9bda085b6ecab7aa16a2bc8aa5cde3f2ba8fb71b2af94f79a
- Response HTTP status: 200
- Prompt tokens: 27955
- Completion tokens: 8666
- Reasoning tokens: 0
- Total tokens: 36621
- API requests reported: 2
- Elapsed seconds: 212.997
- RAG status: reused_or_ready
- RAG records/genes reported: 100
- RAG elapsed seconds: 1095.213
- Question handoff seconds: 1109.559
- Final benchmark system: E2seq; file rank 2/5; original repeat 2; model vendor: Zhipu AI

---
# Multidimensional Interpretation of Ulcerative Colitis Mucosal Transcriptomics

## 1. Overall Biological Interpretation

The transcriptomic profile of ulcerative colitis (UC) versus healthy colonic mucosa reveals a bipartite pathology: a strong inflammatory and immune-activating program superimposed on a profound loss of normal colonic epithelial absorptive and metabolic functions. The upregulated gene set is dominated by innate immune mediators (S100A8, LCN2, CXCL1/2/3, IL1RN, SOCS3), antimicrobial oxidative burst components (DUOX2, DUOXA2), and extracellular matrix (ECM) remodeling factors (MMP3, TIMP1, TNC), consistent with active mucosal inflammation and tissue damage. In contrast, the downregulated genes are enriched for solute transporters (SLC family members, aquaporins), colonic epithelial metabolic enzymes (HMGCS2, G6PC, CYP2B6), and bile acid metabolism genes (SLC51A, ABCB11, ABCG2), indicating a functional dedifferentiation or loss of mature colonocyte capacity. External statistical validation was not performed; the following interpretation is grounded in the uploaded dataset and contextualized by external database annotations and literature.

---

## 2. Core Biological Programs

### Program 1: Innate Immune and Neutrophil-Mediated Inflammation
- **Direction:** Upregulated
- **Major supporting genes:** S100A8 (log2FC = 3.80), LCN2 (log2FC = 2.67), CXCL1 (log2FC = 3.46), CXCL2 (log2FC = 2.80), CXCL3 (log2FC = 2.33), IL1RN (log2FC = 2.88), SOCS3 (log2FC = 2.79), IRAK3 (log2FC = 1.78), S100P (log2FC = 1.78)
- **Standardized pathway:** KEGG IL-17 signaling pathway (retrieved); Hallmark: Inflammatory Response; Reactome: Cytokine Signaling in Immune System
- **Explanation:** The convergence of neutrophil chemoattractants (CXCL1/2/3), alarmin/calgranulin S100A8, the neutrophil-derived antimicrobial lipocalin-2 (LCN2), and negative regulators of innate signaling (SOCS3, IRAK3, IL1RN) collectively indicates active neutrophil infiltration and IL-1/TLR-driven inflammatory signaling in the UC mucosa. The CXCL chemokines share the CXCR2 receptor (STRING network evidence), forming a coherent neutrophil-recruitment axis.
- **Evidence strength:** Strong direct evidence from the uploaded statistics (all FDR < 1e-10). Pathway recurrence (KEGG IL-17 signaling) and STRING network edges (CXCR2 linking CXCL1/2/3) provide consistent contextual support. Literature records confirm UC-associated biomarker studies (PMID: 41029776).
- **Limitations:** The relative contribution of infiltrating neutrophils versus resident epithelial expression cannot be distinguished without cell-type deconvolution.

### Program 2: Reactive Oxygen Species and Antimicrobial Defense
- **Direction:** Upregulated
- **Major supporting genes:** DUOX2 (log2FC = 4.67), DUOXA2 (log2FC = 2.89), CHI3L1 (log2FC = 4.59), TGM2 (log2FC = 1.91), PI3 (log2FC = 2.21), REG4 (log2FC = 2.05)
- **Standardized pathway:** Reactome: Detoxification of Reactive Oxygen Species (R-HSA-3299685, retrieved for AQP8 and related genes); GO: Response to oxidative stress
- **Explanation:** DUOX2 and its maturation factor DUOXA2 form the primary epithelial NADPH oxidase complex generating hydrogen peroxide in the intestinal mucosa, serving as a first-line antimicrobial defense. Their coordinate upregulation, alongside TGM2 (transglutaminase 2, involved in epithelial stress responses) and CHI3L1 (chitinase-like protein implicated in inflammation and tissue injury), indicates an activated epithelial antimicrobial and oxidative stress program.
- **Evidence strength:** Very strong direct statistics (DUOX2 FDR = 4.45e-26; DUOXA2 FDR = 1.12e-10). The DUOX2–DUOXA2 functional complex is well-established in literature. STRING network evidence links AOX1 to CYP2B6 and MOCS1, which may reflect broader oxidative metabolism changes.
- **Limitations:** Elevated DUOX2 may be a consequence rather than a driver of inflammation; causality cannot be inferred from this cross-sectional comparison.

### Program 3: Epithelial Transport and Fluid Homeostasis Loss
- **Direction:** Downregulated
- **Major supporting genes:** SLC6A14 (log2FC = +4.85, upregulated — exception), SLC38A4 (log2FC = −3.07), SLC23A1 (log2FC = −2.40), SLC16A1 (log2FC = −2.38), SLC51A (log2FC = −3.71), AQP7 (log2FC = −2.32), AQP8 (log2FC = −4.42), SLC25A34 (log2FC = −1.93), SLC19A3 (log2FC = −1.34), SLC23A3 (log2FC = −1.93)
- **Standardized pathway:** GO: Fluid Transport (GO:0042044), GO: Water Transport (GO:0006833), GO: Carboxylic Acid Transport (GO:0046942); KEGG: Bile secretion
- **Explanation:** The coordinate downregulation of multiple solute carriers (SLC38A4, SLC16A1, SLC23A1/3, SLC51A) and water channels (AQP7, AQP8) reflects a loss of mature epithelial absorptive and secretory function. AQP8 is the predominant colonic water channel, and its 4.4-log2-fold suppression is a particularly striking marker of epithelial dysfunction. Notably, SLC6A14 is strongly upregulated — this amino acid transporter is induced during inflammatory stress and represents an exception within the broader transport program. The retrieved GO batch for Fluid Transport, Water Transport, and Carboxylic Acid Transport confirms this as a coherent program. STRING evidence links AQP7 and AQP8 to AQP11 and AQP12A, indicating a broader aquaporin network disruption.
- **Evidence strength:** Strong direct statistics across multiple independent genes (all FDR < 1e-10). GO and KEGG pathway annotations are concordant. GTEx and Human Protein Atlas records confirm colonic expression for AQP8, SLC51A, and others.
- **Limitations:** Downregulation of transporters could reflect either transcriptional repression in intact epithelium or replacement of epithelial cells by inflammatory infiltrate. These alternatives require histological or single-cell resolution.

### Program 4: ECM Remodeling and Mesenchymal Activation
- **Direction:** Upregulated
- **Major supporting genes:** MMP3 (log2FC = 4.64), TIMP1 (log2FC = 1.97), TNC (log2FC = 2.58), PRRX1 (log2FC = 2.91), PDPN (log2FC = 2.54), CDH3 (log2FC = 2.29), FILIP1L (log2FC = 1.86), TGM2 (log2FC = 1.91)
- **Standardized pathway:** Reactome: Extracellular Matrix Organization (R-HSA-1474244); GO: Extracellular Structure Organization
- **Explanation:** The simultaneous upregulation of matrix metalloproteinase 3 (MMP3), its inhibitor TIMP1, the matricellular protein tenascin-C (TNC), the mesenchymal marker PRRX1, and epithelial-to-mesenchymal transition–associated factors (CDH3, PDPN, TGM2) indicates active tissue remodeling characteristic of chronic mucosal injury and wound-healing responses. STRING network evidence links ITGB1 to TGM2, TNC, and FREM2, suggesting an integrin-mediated ECM signaling module.
- **Evidence strength:** Strong direct statistics (MMP3 FDR = 5.40e-14; TNC FDR = 2.51e-11). STRING network edges (ITGB1 connecting TGM2, TNC, FREM2) provide structural support for a coordinated ECM module.
- **Limitations:** MMP3 and TIMP1 upregulation is not specific to UC and may reflect any inflammatory tissue-destructive process.

### Program 5: Colonic Epithelial Metabolic Reprogramming
- **Direction:** Downregulated (with notable exceptions)
- **Major supporting genes:** HMGCS2 (log2FC = −3.45), G6PC (log2FC = −1.52), CYP2B6 (log2FC = −2.78), HSD3B2 (log2FC = −2.77), UGT2A3 (log2FC = −2.68), MEP1B (log2FC = −2.99), GBA3 (log2FC = −3.00), NAT8B (log2FC = −1.31), ETNK1 (log2FC = −1.58), ACSF2 (log2FC = −1.93), TAT (log2FC = −1.19), MOCS1 (log2FC = −1.57), LIPC (log2FC = −1.57)
- **Standardized pathway:** KEGG: Bile secretion; Reactome: Metabolism of Lipids and Lipoproteins; Reactome: Biological Oxidations
- **Explanation:** HMGCS2 encodes the rate-limiting enzyme for colonic ketogenesis (β-hydroxybutyrate production), a hallmark metabolic function of differentiated colonocytes utilizing short-chain fatty acids from the microbiota. Its 3.4-log2-fold suppression, alongside downregulation of gluconeogenesis (G6PC), bile acid transport (SLC51A, ABCB11, ABCG2), xenobiotic metabolism (CYP2B6, UGT2A3), and steroid metabolism (HSD3B2), indicates a comprehensive loss of the characteristic metabolic identity of mature colonocytes. This is consistent with a shift from oxidative metabolism to glycolytic/inflammatory metabolism in the diseased mucosa.
- **Evidence strength:** Strong direct statistics across many genes (HMGCS2 FDR = 1.10e-16; CYP2B6 FDR = 4.18e-13). KEGG bile secretion pathway retrieval is concordant. Multiple independent metabolic genes support a broad program rather than a single-gene artifact.
- **Limitations:** The metabolic gene set overlaps significantly with the epithelial transport program (Program 3); both may share a common underlying cause (loss of mature colonocytes). Disentangling metabolic reprogramming from cell-composition change requires single-cell or spatial transcriptomics.

---

## 3. Key Genes and Interaction Modules

### 1. DUOX2 / DUOXA2 Module
- **Statistical direction:** Both upregulated (DUOX2 log2FC = 4.67, FDR = 4.45e-26; DUOXA2 log2FC = 2.89, FDR = 1.12e-10)
- **Program:** Reactive oxygen species and antimicrobial defense (Program 2)
- **Gene-gene relationship:** **Direct physical interaction** — DUOXA2 is the obligate maturation factor for DUOX2; they form a functional NADPH oxidase complex at the apical membrane of intestinal epithelial cells. STRING evidence also links this module to broader oxidative metabolism genes.

### 2. CXCL1 / CXCL2 / CXCL3 – CXCR2 Axis
- **Statistical direction:** All upregulated (CXCL1 log2FC = 3.46, CXCL2 log2FC = 2.80, CXCL3 log2FC = 2.33)
- **Program:** Innate immune and neutrophil-mediated inflammation (Program 1)
- **Gene-gene relationship:** **Pathway co-membership and receptor-level interaction** — All three ligands signal through CXCR2 (not in the dataset but identified via STRING as a network hub). STRING records CXCR2 as a shared interaction partner for all three chemokines. These are **indirect functional relationships** via a shared receptor, not direct physical interactions among the three chemokines themselves. OmniPath additionally links CXCL1 and CXCL2 to ADRA2A via ligand-receptor databases.

### 3. AQP7 / AQP8 Module
- **Statistical direction:** Both downregulated (AQP7 log2FC = −2.32, AQP8 log2FC = −4.42)
- **Program:** Epithelial transport and fluid homeostasis loss (Program 3)
- **Gene-gene relationship:** **Pathway co-membership** — Both are members of the aquaporin family and share Reactome annotation in "Passive transport by Aquaporins" (R-HSA-432047). STRING records edges from AQP7 and AQP8 to AQP11 and AQP12A, but **no direct physical interaction between AQP7 and AQP8 is documented**; their relationship is co-expression and functional family-level co-membership.

### 4. MMP3 / TIMP1 Module
- **Statistical direction:** Both upregulated (MMP3 log2FC = 4.64, TIMP1 log2FC = 1.97)
- **Program:** ECM remodeling and mesenchymal activation (Program 4)
- **Gene-gene relationship:** **Direct physical interaction** — TIMP1 is a direct inhibitor of MMP3, binding the active site of the enzyme. This is a well-established direct protein-protein interaction. Their coordinate upregulation suggests an active but counterbalanced proteolytic process.

### 5. SLC6A14
- **Statistical direction:** Upregulated (log2FC = 4.85, FDR = 8.07e-39 — the most significant gene in the dataset)
- **Program:** Bridges epithelial transport (Program 3) and inflammatory response — SLC6A14 is an amino acid transporter upregulated during inflammatory stress
- **Gene-gene relationship:** No direct interaction partner within the selected gene set; its inclusion here is based on its exceptional statistical significance and potential as a biomarker.

### 6. HMGCS2
- **Statistical direction:** Downregulated (log2FC = −3.45, FDR = 1.10e-16)
- **Program:** Colonic epithelial metabolic reprogramming (Program 5)
- **Gene-gene relationship:** No direct interaction partner in the dataset; its importance is as a sentinel marker of colonocyte metabolic identity loss.

### 7. S100A8
- **Statistical direction:** Upregulated (log2FC = 3.80, FDR = 4.43e-11)
- **Program:** Innate immune and neutrophil-mediated inflammation (Program 1)
- **Gene-gene relationship:** STRING links S100A8 to CDH1 (with CDH3), suggesting **indirect or putative relationship** between S100A8 and epithelial junction remodeling. S100A8 typically heterodimerizes with S100A9 (not in dataset).

### 8. TNC / TGM2 / FREM2 – ITGB1 Module
- **Statistical direction:** TNC up (log2FC = 2.58), TGM2 up (log2FC = 1.91), FREM2 down (log2FC = −1.14)
- **Program:** ECM remodeling (Program 4)
- **Gene-gene relationship:** **Pathway co-membership via shared STRING partner** — ITGB1 (integrin β1, not in dataset) connects TNC, TGM2, and FREM2 in STRING. These are **indirect relationships** mediated by a shared extracellular matrix receptor; no direct physical interactions among the three selected genes are documented.

### 9. CTLA4
- **Statistical direction:** Upregulated (log2FC = 2.62, FDR = 1.11e-10)
- **Program:** Immune regulation within Program 1
- **Gene-gene relationship:** No direct interaction partner within the dataset. CTLA4 is a key T-cell immune checkpoint; its upregulation suggests T-cell activation and regulatory T-cell engagement in the UC mucosa. The upregulated immunoglobulin locus probe (IGHV4-31/IGHM/IGHG1, log2FC = 1.89) is consistent with B-cell/plasma cell infiltration.

### 10. IL1RN / SOCS3 / IRAK3 Regulatory Triad
- **Statistical direction:** All upregulated (IL1RN log2FC = 2.88, SOCS3 log2FC = 2.79, IRAK3 log2FC = 1.78)
- **Program:** Innate immune regulation (Program 1)
- **Gene-gene relationship:** **Regulatory interaction (pathway-level)** — IL1RN is the natural antagonist of IL-1 receptor signaling; SOCS3 is a negative feedback regulator of JAK/STAT and IL-6 signaling; IRAK3 (also called IRAK-M) is a negative regulator of TLR/IL-1R signaling. These three genes are **pathway co-members** in the IL-1/TLR signaling cascade and represent a coordinate negative-feedback response. No direct physical interactions among these three proteins are documented; their relationship is functional and regulatory.

---

## 4. Validation Priorities

### Priority 1: Cell-Composition Deconvolution of the Inflammatory Signal
- **Classification:** Confounding or composition check
- **Why prioritized:** The dominant upregulated program (neutrophil chemokines, S100A8, LCN2) could largely reflect immune cell infiltration rather than epithelial transcriptional changes. This distinction fundamentally changes biological interpretation.
- **Current dataset evidence:** Multiple neutrophil-marker genes (S100A8, LCN2, CXCL1/2/3) are among the most upregulated; their expression could originate from infiltrating neutrophils or activated epithelium.
- **External evidence:** Human Protein Atlas records confirm S100A8 and LCN2 expression in neutrophils; GTEx tissue data show colonic expression for epithelial genes but not immune markers.
- **Next step:** Apply cell-type deconvolution (CIBERSORTx, xCell, or single-cell RNA-seq reference-based decomposition) to the UC and control samples; if raw counts are available, perform cell-type-specific analysis.
- **Conclusion status:** Exploratory hypothesis — the confounding possibility is recognized but unresolved.

### Priority 2: SLC6A14 as a Therapeutic and Biomarker Candidate
- **Classification:** Biomarker / Therapeutic target
- **Why prioritized:** SLC6A14 is the most statistically significant gene in the dataset (log2FC = 4.85, FDR = 8.07e-39), with an exceptionally large effect size suggesting potential diagnostic sensitivity.
- **Current dataset evidence:** Strongest direct signal; approximately 28-fold upregulation in UC.
- **External evidence:** SLC6A14 is an amino acid transporter with known intestinal expression; it has been studied as a potential target in cancer (cBioPortal records). GutMGene records indicate intestinal relevance. However, no UC-specific clinical trial or independent UC cohort statistic was supplied.
- **Next step:** Validate SLC6A14 protein expression in UC versus control mucosa by immunohistochemistry; test its diagnostic performance in an independent UC cohort; evaluate whether SLC6A14 inhibition reduces amino acid–driven inflammatory signaling in intestinal organoids.
- **Conclusion status:** Supported hypothesis (as biomarker); Exploratory hypothesis (as therapeutic target — drug target existence does not establish efficacy in UC).

### Priority 3: DUOX2/DUOXA2-Mediated Oxidative Stress as a Mechanistic Driver
- **Classification:** Mechanistic hypothesis
- **Why prioritized:** The DUOX2/DUOXA2 complex is the major epithelial source of reactive oxygen species in the gut; its 4.7-log2-fold upregulation suggests a potential causal role in epithelial damage.
- **Current dataset evidence:** DUOX2 is the second most upregulated gene (log2FC = 4.67); DUOXA2 is concordantly upregulated (log2FC = 2.89), consistent with functional complex formation.
- **External evidence:** DUOX2 is well-established in intestinal biology and IBD literature; Reactome and UniProt annotations confirm its role in epithelial H₂O₂ production. No independent UC cohort statistic was supplied.
- **Next step:** Measure DUOX2-dependent ROS production in UC biopsies versus controls; test whether DUOX2 inhibition reduces epithelial barrier dysfunction in organoid or mouse colitis models.
- **Conclusion status:** Supported hypothesis — the upregulation is robust and the mechanism is biologically plausible, but causality is not established.

### Priority 4: HMGCS2 and Metabolic Reprogramming as a Marker of Epithelial Differentiation Loss
- **Classification:** Biomarker
- **Why prioritized:** HMGCS2 is a master regulator of colonic ketogenesis and a sentinel of colonocyte metabolic identity; its suppression (log2FC = −3.45) may mark the degree of epithelial dedifferentiation.
- **Current dataset evidence:** Strong downregulation with high significance (FDR = 1.10e-16); accompanied by concordant suppression of G6PC, CYP2B6, and SLC51A, forming a coherent metabolic program.
- **External evidence:** HMGCS2 is established as a colonocyte marker in gut biology literature; GTEx confirms high colonic expression. The relationship between HMGCS2 loss and UC severity requires external validation.
- **Next step:** Correlate HMGCS2 expression with endoscopic severity scores (Mayo score) in an independent UC cohort; evaluate whether HMGCS2 restoration (e.g., via butyrate supplementation) rescues colonocyte metabolic function in organoid models.
- **Conclusion status:** Supported hypothesis.

### Priority 5: CXCL1/2/3–CXCR2 Axis as a Therapeutic Interaction Target
- **Classification:** Interaction / network hypothesis
- **Why prioritized:** The CXCL1/2/3 triad shares CXCR2 as a common receptor (STRING evidence), forming a druggable node; CXCR2 antagonists exist and have been explored in inflammatory disease.
- **Current dataset evidence:** All three chemokines are significantly upregulated (log2FC 2.33–3.46, all FDR < 1e-11).
- **External evidence:** STRING confirms CXCR2 as a shared binding partner. CXCR2 antagonists have been developed (ClinicalTrials.gov records exist for related compounds), but no UC-specific trial data were supplied. Literature links CXCL1 to UC (PMID: 41029776).
- **Next step:** Confirm CXCR2 protein expression in UC mucosa; evaluate CXCR2 blockade in mouse DSS-colitis models; if promising, design a pilot clinical study.
- **Conclusion status:** Exploratory hypothesis — the network is supported, but therapeutic efficacy in UC is untested.

---

## 5. Evidence Grounding

| Program / Claim | Direct Evidence (Input Dataset) | Pathway/Ontology Evidence | Protein/Regulatory Evidence | Disease-Association Evidence | Expression/Tissue Evidence | Literature Evidence | Independent Cohort |
|---|---|---|---|---|---|---|---|
| Innate immune inflammation | S100A8, LCN2, CXCL1/2/3, IL1RN, SOCS3 — all strongly upregulated (FDR < 1e-10) | KEGG IL-17 signaling (retrieved); Hallmark Inflammatory Response | STRING: CXCR2 hub linking CXCL1/2/3; TIMP1–MMP3 direct interaction | ClinVar/GWAS records for multiple genes | GTEx/HPA confirm colonic and immune cell expression | PMID: 41029776 (UC biomarker study) | Not available |
| ROS/antimicrobial defense | DUOX2, DUOXA2, CHI3L1, TGM2 upregulated | Reactome: Detoxification of ROS (R-HSA-3299685) | DUOX2–DUOXA2 direct physical complex (UniProt/Reactome) | OpenTargets records for DUOX2 | HPA confirms intestinal epithelial expression | Established DUOX2–IBD literature | Not available |
| Epithelial transport loss | AQP7, AQP8, SLC38A4, SLC51A, SLC16A1, SLC23A1 downregulated | GO: Fluid Transport, Water Transport, Carboxylic Acid Transport (retrieved batch); KEGG: Bile secretion | STRING: AQP7–AQP8–AQP11–AQP12A network edges | GutMGene records for 8 genes | GTEx confirms colonic expression for AQP8, SLC51A | PMID: 32808743 (ABCB11/BSEP expression) | Not available |
| ECM remodeling | MMP3, TIMP1, TNC, PRRX1, PDPN, CDH3 upregulated | Reactome: ECM Organization | STRING: ITGB1 hub linking TNC, TGM2, FREM2; TIMP1–MMP3 direct interaction | ClinVar records for TNC, COL genes | HPA confirms ECM protein expression | General IBD-remodeling literature | Not available |
| Metabolic reprogramming | HMGCS2, G6PC, CYP2B6, HSD3B2, UGT2A3, MEP1B downregulated | KEGG: Bile secretion; Reactome: Metabolism of Lipids, Biological Oxidations | STRING: AOX1–CYP2B6–MOCS1 edges | GWAS records for multiple metabolic genes | GTEx confirms high colonic HMGCS2 expression | PMID: 25171508 (BRINP3 in UC) | Not available |

**Independence assessment:** The GO/KEGG batch results, STRING edges, Reactome annotations, and GTEx/HPA expression data are derived from different databases but may share underlying gene-annotation or publication sources; they should not be considered fully independent. The PubMed/Europe PMC literature records (e.g., PMID: 41029776) are genuinely independent of the input dataset but may themselves have used overlapping public transcriptomic data. No independent cohort statistic was supplied, so external statistical validation was not performed.

**Conflict note:** SLC6A14 is upregulated while most other SLC transporters are downregulated. This is not necessarily contradictory — SLC6A14 is known to be induced by inflammatory signaling and may represent a stress-responsive transporter, whereas the broader SLC downregulation reflects loss of constitutive epithelial transport capacity.

---

## 6. Limitations and Alternative Explanations

### 1. Cell-Composition Confounding (Most Critical)
The UC mucosa contains increased inflammatory infiltrate (neutrophils, lymphocytes, plasma cells) and decreased intact epithelium relative to healthy controls. Many upregulated genes (S100A8, LCN2, CXCL1/2/3, immunoglobulin loci) may primarily reflect immune cell infiltration rather than epithelial transcriptional change, while downregulated genes (AQP8, HMGCS2, SLC family) may reflect epithelial cell loss rather than transcriptional repression. **Investigation:** Cell-type deconvolution using CIBERSORTx or xCell; laser-capture microdissection of epithelial compartments; single-cell RNA-seq of UC and control mucosa.

### 2. Disease Severity and Heterogeneity
No information on disease severity (Mayo endoscopic subscore, histological grade), anatomic location (pancolitis vs. left-sided), or disease duration was provided. The transcriptomic signature likely differs substantially between mild and severe UC. **Investigation:** Stratify analysis by endoscopic and histological severity scores; compare expression signatures across anatomic segments.

### 3. Treatment Exposure
UC patients are often treated with 5-aminosalicylic acid, corticosteroids, immunomodulators, or biologics, all of which can alter mucosal gene expression. The treatment status of the UC cohort was not specified. For example, corticosteroids suppress CXCL chemokines and could mask or modify the inflammatory signal. **Investigation:** Record and adjust for medication exposure; compare treated versus treatment-naïve patients.

### 4. Batch and Platform Effects
The dataset contains probe identifiers (e.g., PROBE_241592_PM_at, PROBE_227140_PM_at) and grouped/concatenated gene entries (e.g., CYP2B7P|CYP2B6, NAT8B|NAT8, LOC100290146|IGHV4-31|IGHM|IGHG1|IGH), suggesting legacy microarray data. Cross-platform batch effects and probe-to-gene mapping ambiguity could introduce artifacts, particularly for genes with multiple probes or pseudogene cross-hybridization (CYP2B7P is a pseudogene). The 43 duplicate rows in the ledger warrant careful handling. **Investigation:** Confirm probe annotations; validate key genes (SLC6A14, DUOX2, AQP8, HMGCS2) by RNA-seq or qPCR in an independent cohort.

### 5. Association Versus Causation
This cross-sectional comparison identifies genes that are differentially expressed in established UC but cannot determine whether any gene is causally involved in disease pathogenesis. For example, DUOX2 upregulation may be a downstream consequence of inflammation rather than a driver. Similarly, SLC6A14 upregulation may be a response to rather than a cause of epithelial stress. **Investigation:** Functional studies in organoids, mouse models, or Mendelian randomization using GWAS instruments (GWAS data were retrieved for all 100 genes) to assess causal direction.

---

**Summary statement:** The UC mucosal transcriptome is characterized by a robust inflammatory and antimicrobial program (CXCL1/2/3, S100A8, LCN2, DUOX2), active ECM remodeling (MMP3/TIMP1, TNC), and a profound loss of epithelial transport and metabolic functions (AQP8, HMGCS2, SLC family, bile acid metabolism genes), with SLC6A14 standing out as the most significantly upregulated gene. External statistical validation was not performed, and the relative contribution of cell-composition change versus transcriptional regulation remains the most critical unresolved question.

E2seq statistical audit: selected=100, ledger=100, RAG records=100, numeric claims checked=48, external claims checked=0, external mismatches=0, status=needs review.

Answer model API: Zhipu AI / glm-5.2

Source coverage (gene sources = selected items with records / selected RAG items; literature sources = articles / queries)
Online APIs: alliance 94/100 selected items (records returned); cbioportal 87/100 selected items (records returned); chembl 40/100 selected items (partially returned; some queries failed); civic 7/100 selected items (records returned); clinicaltrials 51/100 selected items (records returned); clinvar 90/100 selected items (records returned); ensembl 55/100 selected items (partially returned; some queries failed); europepmc 936 articles / initial full-cohort RAG 100 queries + 4 current-round queries; gtex 91/100 selected items (records returned); gwas 100/100 selected items (records returned); hpa 85/100 selected items (records returned); humanbase 87/100 selected items (records returned); intact 85/100 selected items (records returned); mygene 93/100 selected items (records returned); omnipath 45/100 selected items (records returned); opentargets 92/100 selected items (records returned); pubmed 750 articles / initial full-cohort RAG 100 queries + 3 current-round queries; quickgo 87/100 selected items (records returned); reactome 100/100 selected items (records returned); uniprot 88/100 selected items (records returned)
Local databases: gutmgene 8/100 selected items (records returned); hmdb 46/100 selected items (records returned); string 85/100 selected items (records returned); trrust 31/100 selected items (records returned)
